Cammarota, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 19.143
EU - Europa 14.293
AS - Asia 12.039
SA - Sud America 2.336
Continente sconosciuto - Info sul continente non disponibili 545
AF - Africa 271
OC - Oceania 36
Totale 48.663
Nazione #
US - Stati Uniti d'America 18.595
DE - Germania 5.742
SG - Singapore 5.314
CN - Cina 2.926
IT - Italia 2.190
BR - Brasile 1.889
SE - Svezia 1.579
FR - Francia 1.041
VN - Vietnam 1.040
UA - Ucraina 848
GB - Regno Unito 708
IE - Irlanda 485
BD - Bangladesh 433
IN - India 421
PL - Polonia 411
FI - Finlandia 372
JP - Giappone 354
ID - Indonesia 353
RU - Federazione Russa 273
CA - Canada 270
HK - Hong Kong 265
TR - Turchia 209
AR - Argentina 170
NL - Olanda 138
MX - Messico 129
ES - Italia 116
IQ - Iraq 116
KR - Corea 91
BE - Belgio 90
ZA - Sudafrica 60
PK - Pakistan 59
EC - Ecuador 57
CO - Colombia 56
VE - Venezuela 53
AT - Austria 50
SA - Arabia Saudita 48
CH - Svizzera 41
UZ - Uzbekistan 41
MA - Marocco 36
CL - Cile 35
CZ - Repubblica Ceca 35
IL - Israele 35
IR - Iran 34
JO - Giordania 33
TN - Tunisia 33
KE - Kenya 32
AE - Emirati Arabi Uniti 30
AU - Australia 29
LT - Lituania 28
PH - Filippine 28
EU - Europa 27
JM - Giamaica 27
PY - Paraguay 26
EG - Egitto 24
CR - Costa Rica 22
KZ - Kazakistan 20
NP - Nepal 19
AZ - Azerbaigian 18
PA - Panama 18
PT - Portogallo 18
DZ - Algeria 17
PE - Perù 17
RO - Romania 17
GR - Grecia 15
TW - Taiwan 15
UY - Uruguay 15
BH - Bahrain 14
BO - Bolivia 14
CI - Costa d'Avorio 14
OM - Oman 14
MY - Malesia 13
HR - Croazia 12
RS - Serbia 12
TH - Thailandia 12
TT - Trinidad e Tobago 12
LK - Sri Lanka 11
HU - Ungheria 10
LB - Libano 10
NI - Nicaragua 10
DO - Repubblica Dominicana 9
ET - Etiopia 9
GE - Georgia 9
GT - Guatemala 9
HN - Honduras 9
AL - Albania 8
NG - Nigeria 8
BB - Barbados 7
BY - Bielorussia 7
BG - Bulgaria 6
BZ - Belize 6
KG - Kirghizistan 6
KW - Kuwait 6
LV - Lettonia 6
SK - Slovacchia (Repubblica Slovacca) 6
SN - Senegal 6
SV - El Salvador 6
SY - Repubblica araba siriana 6
XK - ???statistics.table.value.countryCode.XK??? 6
AO - Angola 5
CY - Cipro 5
Totale 48.039
Città #
Singapore 2.758
Ashburn 1.984
Chandler 1.777
San Jose 1.617
Beijing 500
Jacksonville 492
Dublin 477
New York 393
Los Angeles 386
San Mateo 383
Nürnberg 378
Ann Arbor 359
Ho Chi Minh City 346
Rome 342
Hefei 327
Jakarta 318
Lauterbourg 315
Tokyo 303
Nanjing 302
Milan 290
Warsaw 289
Hanoi 254
Hong Kong 240
Boston 239
Woodbridge 232
Wilmington 230
Munich 215
Dallas 199
Frankfurt am Main 194
Cattolica 188
Marseille 168
Dearborn 167
Houston 158
Santa Clara 154
Princeton 153
Chicago 151
São Paulo 150
Seattle 143
Moscow 138
Buffalo 137
Fairfield 137
Atlanta 134
Izmir 134
Boardman 132
The Dalles 132
St Louis 128
Redwood City 125
Nanchang 113
Council Bluffs 110
Helsinki 105
Kent 91
Lawrence 89
Shanghai 88
Seoul 84
Brussels 81
London 81
Kraków 75
Phoenix 75
Turku 75
Shenyang 74
Orem 72
San Francisco 72
Hangzhou 71
Fuzhou 68
Toronto 68
Brooklyn 67
Denver 66
Rio de Janeiro 65
Lancaster 60
Verona 60
Guangzhou 59
Redmond 59
Memphis 58
Nuremberg 58
Paris 58
Bremen 57
Hebei 57
Montreal 54
Mountain View 54
Leawood 52
Da Nang 51
Las Vegas 50
Pune 50
Baghdad 49
Belo Horizonte 49
Tianjin 49
Zhengzhou 49
Stockholm 48
Changsha 47
Kunming 47
University Park 44
Cambridge 41
Amsterdam 40
Chennai 40
Haiphong 40
Düsseldorf 38
Norwalk 38
Fremont 37
Johannesburg 36
Naples 35
Totale 22.022
Nome #
Consorzio di probiotici / Probiotic mixture 548
Post-cholecystectomy alkaline reactive gastritis: a randomized trial comparing sucralfate versus rabeprazole or no treatment 528
-Rifaximin dose-finding study for the treatment of small intestinal bacterial overgrowth 510
Small intestinal bacterial overgrowth recurrence after antibiotic therapy 493
Nickel free-diet enhances the Helicobacter pylori eradication rate: a pilot study. 476
Gut microbiota in anxiety and depression: Pathogenesis and therapeutics 453
A Durum Wheat Variety-Based Product Is Effective in Reducing Symptoms in Patients with Non-Celiac Gluten Sensitivity: A Double-Blind Randomized Cross-Over Trial 447
A case-control study comparing methylene blue directed biopsies and random biopsies for detecting pre-cancerous lesions in the follow-up of gastric cancer patients 438
Image-Enhanced Endoscopy with I-scan Technology for the Evaluation of Duodenal Villous Patterns 437
gc) Biofilm demolition and antibiotic treatment to eradicate resistant Helicobacter pylori: a clinical trial. 421
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility 377
A) High levels of dual resistance to clarithromycin and metronidazole and in vitro activity of levofloxacin against Helicobacter pylori isolates from patients after failure of therapy. 337
Relationship between gastric localization of hepatitis C virus and mucosa-associated lymphoid tissue in Helicobacter pylori infection 336
Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study 330
Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders? 324
Short-Chain Fatty-Acid-Producing Bacteria: Key Components of the Human Gut Microbiota 315
gc) Water-immersion technique during standard upper endoscopy may be useful to drive the biopsy sampling of duodenal mucosa in children with celiac disease. 310
International consensus conference on stool banking for faecal microbiota transplantation in clinical practice 291
Fecal microbiota transplantation for recurrent Clostridioides difficile infection in patients with concurrent ulcerative colitis 289
-Accuracy of laryngeal examination during upper gastrointestinal endoscopy for premalignancy screening: prospective study in patients with and without reflux symptoms. 278
FECAL CALPROTECTIN AND NEED OF MULTIPLE MICROBIOTA TRANSPLANTATION INFUSIONS IN CLOSTRIDIUM DIFFICILE INFECTION 278
ag)Association between hypothyroidism and small intestinal bacterial overgrowth 273
A) Lack of endoscopic visualization of intestinal villi with the "immersion technique" in overt atrophic celiac disease 268
Classification of malabsorption syndromes. 263
Role of gut microbiome on immunotherapy efficacy in melanoma 260
High accuracy and cost-effectiveness of a biopsy-avoiding endoscopic approach in diagnosing coeliac disease. 260
The microbiome-driven impact of western diet in the development of noncommunicable chronic disorders 254
A highly accurate method for monitoring histological recovery in patients with celiac disease on a gluten-free diet using an endoscopic approach that avoids the need for biopsy: a double-center study 254
gc) Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. 252
Wheat desensitization treatment in patients with gluten sensitivity 242
Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study 237
Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide 237
A) Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial. 231
-High prevalence of celiac disease in patients with lactose intolerance 231
Identification of spatially-resolved markers of malignant transformation in Intraductal Papillary Mucinous Neoplasms 227
T-bet and pSTAT1 expression in peripheral blood mononuclear cells from coeliac disease patients: new markers of disease activity 227
The involvement of gut microbiota in inflammatory bowel disease pathogenesis: Potential for therapy 223
-Moxifloxacin-based strategies for first-line treatment of Helicobacter pylori infection. 218
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 218
The role of diet on gut microbiota composition 218
A) Reliability of the "immersion technique" during routine upper endoscopy for detection of abnormalities of duodenal villi in patients with dyspepsia. 216
Donor program for fecal microbiota transplantation: A 3-year experience of a large-volume Italian stool bank 215
gc) Patchy left-sided colitis: primary eosinophilic colitis or paraneoplastic syndrome ? 212
Role and mechanisms of action of Escherichia coli nissle 1917 in the maintenance of remission in ulcerative colitis patients: an update 212
The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease 211
Diagnostic and therapeutic impact of double-balloon enteroscopy (DBE) in a series of 100 patients with suspected small bowel diseases 211
Can chronic gastritis cause an increase in fecal calprotectin concentrations? 210
Decrease in Surgery for Clostridium difficile Infection After Starting a Program to Transplant Fecal Microbiota 208
(gc)Association of laryngeal cancer with previous gastric resection. 207
GC)Optimal band imaging system: a new tool for enhancing the duodenal villous pattern in celiac disease. 207
Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication 204
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 204
Celiac disease: what's new about it? 198
International consensus statement on microbiome testing in clinical practice 197
Gut microbiome, big data and machine learning to promote precision medicine for cancer 195
Fecal microbiota transplantation: Past, present and future perspectives 194
Combined atherogenic effects of celiac disease and type 1 diabetes mellitus 193
Dramatic improvement of parkinsonian symptoms after gluten-free diet introduction in a patient with silent celiac disease 193
. Adverse reactions to food: allergies and intolerances. 192
Key determinants of success in fecal microbiota transplantation: From microbiome to clinic 189
A) Association of laryngeal cancer with previous gastric resection 189
Helicobacter pylori eradication rate and glycemic control in young patients with type 1 diabetes 188
Increased expression of T-bet in circulating B cells from a patient with multiple sclerosis and celiac disease 188
Donor screening for fecal microbiota transplantation with a direct stool testing-based strategy: a prospective cohort study 187
Can chronic gastritis cause increase of fecal calprotectin concentrations? 186
Nickel free-diet enhances the Helicobacter pylori eradication rate: a pilot study 186
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis 184
[Helicobacter pylori infection: from gastric to systemic disease] 182
Histamine-producing bacteria and their role in gastrointestinal disorders 181
Combined atherogenic effects of celiac disease and type 1 diabetes mellitus 181
Fecal calprotectin concentrations in patients with small intestinal bacterial overgrowth. 180
gc) Celiac disease in the 21st century: issues of under- and over-diagnosis 179
Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment: a randomized trial. 176
High dosage rifaximin for the treatment of small intestinal bacterial overgrowth. 176
Image-Enhanced Endoscopy with I-scan Technology for the Evaluation of Duodenal Villous Patterns. 176
The Detrimental Impact of Ultra-Processed Foods on the Human Gut Microbiome and Gut Barrier 173
Cystic lymphangioma of the mesentery and hyposplenism in celiac disease. 173
Locally injected Infliximab ameliorates murine DSS colitis: differences in serum and intestinal levels of drug between healthy and colitic mice 172
-Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth 171
Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders 171
Fine-tuning the gut ecosystem: the current landscape and outlook of artificial microbiome therapeutics 170
ag) Fecal calprotectin in first-degree relatives of patients with ulcerative colitis. 170
Improved gut microbiota features after the resolution of SARS‑CoV‑2 infection 170
-Double-balloon enteroscopy for diagnosis of a Meckel's diverticulum in a patient with GI bleeding of obscure origin 168
Fecal calprotectin concentrations in patients with small intestinal bacterial overgrowth. 168
Image-enhanced endoscopy with I-scan technology for the evaluation of duodenal villous patterns 166
FETR-ALS Study Protocol: A Randomized Clinical Trial of Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis 166
Gastrointestinal involvement of autism spectrum disorder: focus on gut microbiota 165
Fecal calprotectin in first-degree relatives of patients with ulcerative colitis 164
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. 164
Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a three-year, single-centre cohort study 163
. Quick test: a new test for the diagnosis of duodenal hypolactasia. 161
A) Gastric surgery as a long-term risk factor for malignant lesions of the larynx. 161
gc) Tired legs a gut diagnosis 161
Microscopic colitis 161
Henoch–schonlein purpura following exposure to SARS-CoV2 vaccine or infection: a systematic review and a case report 160
The role of IL-15 in gastrointestinal diseases: a bridge between innate and adaptive immune response 160
European consensus conference on faecal microbiota transplantation in clinical practice 160
Prophylactic aspirin therapy does not increase faecal calprotectin concentrations. 159
Levofloxacin based regimens for the eradication of Helicobacter pylori 158
Totale 23.751
Categoria #
all - tutte 183.643
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 183.643


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.976 0 185 57 129 130 89 39 337 97 95 388 430
2022/20234.882 628 658 365 732 320 599 247 386 596 94 159 98
2023/20242.645 133 704 90 173 119 318 175 95 70 156 322 290
2024/20255.946 148 198 470 167 456 189 165 326 831 588 1.257 1.151
2025/202616.516 2.423 534 951 1.672 2.551 1.127 2.691 806 1.084 1.128 776 773
2026/20274.846 1.400 3.446 0 0 0 0 0 0 0 0 0 0
Totale 48.663